Gemtesa 75 MG tablet 90S
Ended Awarded
- Contract number
- SPE2DB25FJL43
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $6,901
Award facts
- Contract value 100% obligated
- $6,900.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,900.70 to AmerisourceBergen Drug Corp for 90 tablets of Gemtesa 75 mg on August 15, 2025, with completion expected by August 18, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA's Medical Supply Chain.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The underlying IDC functions as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a wide range of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. Gemtesa (mirabegron), a medication used to treat overactive bladder, represents one of the specialized pharmaceutical products AmerisourceBergen Drug Corp delivers to support Defense Health Agency requirements and other government healthcare systems through this flexible contract vehicle.
Quick answers
Who was awarded contract SPE2DB25FJL43?
SPE2DB25FJL43 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 15, 2025.
How much is contract SPE2DB25FJL43 worth?
The government has obligated $6,901 on SPE2DB25FJL43.
Is contract SPE2DB25FJL43 an order under another contract?
Yes. SPE2DB25FJL43 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FJL43 competed?
The extent of competition for SPE2DB25FJL43 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award